Your Source for Venture Capital and Private Equity Financings

Expansion Therapeutics Raises $80M Series B

2021-09-29
BOSTON, MA, Expansion Therapeutics, a biotechnology company, has closed an $80 million Series B financing led by Cormorant Asset Management.
Expansion Therapeutics, a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases, has closed an $80 million Series B financing.

Cormorant Asset Management led the financing with participation from new investors Westlake Village BioPartners, Surveyor Capital (a Citadel company) and Logos Capital as well as Series A investors RA Capital Management, 5AM Ventures, Kleiner Perkins, Sanofi Ventures and Novartis Venture Fund.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors


Featured Reading